<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">iScience</journal-id>
<journal-id journal-id-type="iso-abbrev">iScience</journal-id>
<journal-title-group>
<journal-title>iScience</journal-title>
</journal-title-group>
<issn pub-type="epub">2589-0042</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31546104</article-id>
<article-id pub-id-type="pmc">6817635</article-id>
<article-id pub-id-type="publisher-id">S2589-0042(19)30342-6</article-id>
<article-id pub-id-type="doi">10.1016/j.isci.2019.09.005</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Apical-Basal Polarity Signaling Components, Lgl1 and aPKCs, Control Glutamatergic Synapse Number and Function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Scott</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Thakar</surname>
<given-names>Sonal</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Mao</surname>
<given-names>Ye</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Qin</surname>
<given-names>Huaping</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au5">
<name>
<surname>Hejran</surname>
<given-names>Helen</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au6">
<name>
<surname>Lee</surname>
<given-names>Su-Yee</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au7">
<name>
<surname>Yu</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au8">
<name>
<surname>Klezovitch</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author" id="au9">
<name>
<surname>Cheng</surname>
<given-names>Hongqiang</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" id="au10">
<name>
<surname>Mu</surname>
<given-names>Yongxin</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" id="au11">
<name>
<surname>Ghosh</surname>
<given-names>Sourav</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author" id="au12">
<name>
<surname>Vasioukhin</surname>
<given-names>Valeri</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author" id="au13">
<name>
<surname>Zou</surname>
<given-names>Yimin</given-names>
</name>
<email>yzou@ucsd.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Neurobiology Section, Biological Sciences Division, University of California, San Diego, La Jolla, CA 92093, USA</aff>
<aff id="aff2"><label>2</label>Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</aff>
<aff id="aff3"><label>3</label>Department of Neurology, Yale University, New Haven, CT 06511, USA</aff>
<aff id="aff4"><label>4</label>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>yzou@ucsd.edu</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>09</day>
<month>9</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<day>25</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>9</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<fpage>25</fpage>
<lpage>41</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Author(s)</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<title>Summary</title>
<p>Normal synapse formation is fundamental to brain function. We show here that an apical-basal polarity (A-BP) protein, Lgl1, is present in the postsynaptic density and negatively regulates glutamatergic synapse numbers by antagonizing the atypical protein kinase Cs (aPKCs). A planar cell polarity protein, Vangl2, which inhibits synapse formation, was decreased in synaptosome fractions of cultured cortical neurons from <italic>Lgl1</italic> knockout embryos. Conditional knockout of <italic>Lgl1</italic> in pyramidal neurons led to reduction of AMPA/NMDA ratio and impaired plasticity. <italic>Lgl1</italic> is frequently deleted in Smith-Magenis syndrome (SMS). Lgl1 conditional knockout led to increased locomotion, impaired novel object recognition and social interaction. <italic>Lgl1+/−</italic> animals also showed increased synapse numbers, defects in open field and social interaction, as well as stereotyped repetitive behavior. Social interaction in <italic>Lgl1+/−</italic> could be rescued by NMDA antagonists. Our findings reveal a role of apical-basal polarity proteins in glutamatergic synapse development and function and also suggest a potential treatment for SMS patients with <italic>Lgl1</italic> deletion.</p>
</abstract>
<abstract abstract-type="graphical" id="abs0015">
<title>Graphical Abstract</title>
<fig id="undfig1" position="anchor">
<graphic xlink:href="fx1"></graphic>
</fig>
</abstract>
<abstract abstract-type="author-highlights" id="abs0020">
<title>Highlights</title>
<p>
<list id="ulist0010" list-type="simple">
<list-item id="u0010">
<label>•</label>
<p id="p0010">Lgl1 regulates glutamatergic synapse numbers by inhibiting aPKC</p>
</list-item>
<list-item id="u0015">
<label>•</label>
<p id="p0015"><italic>Lgl1 cKO</italic> leads to reduced AMPA/NMDA ratio in development and adulthood</p>
</list-item>
<list-item id="u0020">
<label>•</label>
<p id="p0020"><italic>Lgl1</italic> conditional knockout impairs novel object cognition and social interaction</p>
</list-item>
<list-item id="u0025">
<label>•</label>
<p id="p0025">Social interaction deficits can be rescued by NMDA receptor blockade</p>
</list-item>
</list>
</p>
</abstract>
<abstract abstract-type="teaser" id="abs0025">
<p>Biological Sciences; Cell Biology; Cellular Neuroscience; Neuroscience</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Subject Areas</title>
<kwd>Biological Sciences</kwd>
<kwd>Cell Biology</kwd>
<kwd>Cellular Neuroscience</kwd>
<kwd>Neuroscience</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: October 25, 2019</p>
</notes>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p id="p0030">Glutamatergic synapses are the major class of excitatory synapses in the mammalian central nervous system (<xref ref-type="bibr" rid="bib5">Collingridge et al., 1983</xref>, <xref ref-type="bibr" rid="bib24">Monaghan et al., 1989</xref>, <xref ref-type="bibr" rid="bib33">Watkins and Evans, 1981</xref>). Normal development and plasticity of glutamatergic synapses are essential to the emergence of normal behavioral functions, the disruption of which causes various neurological and neuropsychiatric disorders. A recent study showed that components of planar cell polarity (PCP) signaling pathway are key regulators of glutamatergic synapse formation (<xref ref-type="bibr" rid="bib30">Thakar et al., 2017</xref>). Celsr3 is essential for glutamatergic synapse formation, whereas Vangl2 negatively regulates glutamatergic synapse formation. Therefore, PCP signaling components can both positively and negatively regulate glutamatergic synapse numbers.</p>
<p id="p0035">Lethal giant larvae (Lgl1) is a key component of the highly conserved apical-basal polarity signaling pathway, which polarizes epithelial cells along the apical and basolateral axis (<xref ref-type="bibr" rid="bib17">Karner et al., 2006</xref>). Lgl1 forms the basolateral complexes with Scribble and Discs Large (Dlg) and mutually excludes and antagonizes the function of the apical complex, the aPKC/Par3/Par6 complex. Lgl1 has been implicated in polarized exocytosis and is essential for establishing or maintaining apical-basal polarity (<xref ref-type="bibr" rid="bib1">Betschinger et al., 2003</xref>, <xref ref-type="bibr" rid="bib10">Georgiou et al., 2008</xref>, <xref ref-type="bibr" rid="bib22">Macara, 2004</xref>, <xref ref-type="bibr" rid="bib35">Yamanaka et al., 2003</xref>, <xref ref-type="bibr" rid="bib34">Yamanaka et al., 2006</xref>). Dlg homologs are important postsynaptic scaffold proteins, called <italic>MAGUKs</italic> (<xref ref-type="bibr" rid="bib38">Zhu et al., 2016</xref>). MAGUK proteins play essential roles in postsynaptic density organization and glutamate receptor trafficking and clustering. In addition, Lgl1 has been shown to associate and co-traffic with FMRP (<xref ref-type="bibr" rid="bib37">Zarnescu et al., 2005</xref>), a translational regulator of many synaptic components. Apical-basal and planar polarity pathways are known to interact with each other. For example, apical-basal polarity signaling has been recently shown to regulate the location of PCP signaling (<xref ref-type="bibr" rid="bib4">Chuykin et al., 2018</xref>).</p>
<p id="p0040">Here we report that conditional knockout of <italic>Lgl1</italic> from postnatal day 7 (P7) in hippocampal pyramidal neurons, before the peak of glutamatergic synapse formation, resulted in increased glutamatergic synapse density. In <italic>aPKC</italic> double conditional knockout (KO) (dcKO), glutamatergic synapse numbers were initially normal (at P14) but were reduced in adulthood. <italic>Triple conditional KO (tcKO)</italic> of <italic>Lgl1</italic> and <italic>aPKCs</italic> rescued the defects of synapse numbers in <italic>Lgl1 cKO</italic>. In the synaptosome fraction of cultured <italic>Lgl1−/−</italic> neurons Vangl2 was found decreased. <italic>Lgl1 cKO</italic> and <italic>aPKC dcKO</italic> led to opposite changes in ultrastructure, with loss of Lgl1 leading to a larger postsynaptic density and smaller synaptic cleft. <italic>Lgl1 cKO</italic> also showed reduced AMPA/NMDA receptor ratio. Deleting Lgl1 in adulthood also led to increased synapse numbers and a much greater reduction of AMPA/NMDA receptor ratio, as well as deficit in long-term potentiation. These results suggest that Lgl1 regulates glutamate receptor trafficking, potentially through its binding partners, the MAGUK proteins. Therefore, together with PCP signaling, apical-basal signaling also has a profound influence on synapse formation, forming another layer of regulation, potentially allowing additional regulatory inputs.</p>
<p id="p0045"><italic>Lgl1</italic> is frequently deleted in a chromosome 17 p11.2 microdeletion disorder, called Smith-Magenis syndrome (SMS) (<xref ref-type="bibr" rid="bib28">Smith et al., 1986</xref>). SMS is a <italic>de novo</italic> genetic disorder arising very early in embryonic development through homologous recombination (<xref ref-type="bibr" rid="bib2">Chen et al., 1997</xref>). A deletion interval of 3.5 Mb occurs in approximately 70% of patients (<xref ref-type="bibr" rid="bib14">Gropman et al., 2007</xref>). Individuals with the deletion are frequently diagnosed with autism spectrum disorders (ASDs), attention-deficit/hyperactivity disorder, obsessive-compulsive disorder (OCD), or other behavioral disorders (<xref ref-type="bibr" rid="bib7">Dykens et al., 1997</xref>, <xref ref-type="bibr" rid="bib8">Dykens and Smith, 1998</xref>, <xref ref-type="bibr" rid="bib21">Laje et al., 2010</xref>, <xref ref-type="bibr" rid="bib23">Martin et al., 2006</xref>, <xref ref-type="bibr" rid="bib27">Smith et al., 1998</xref>). Symptoms vary between individuals despite common deletions (<xref ref-type="bibr" rid="bib9">Edelman et al., 2007</xref>, <xref ref-type="bibr" rid="bib26">Potocki et al., 2003</xref>), and multiple genes likely contribute to the syndrome (<xref ref-type="bibr" rid="bib11">Girirajan et al., 2006</xref>). Recent work has implicated <italic>Rai1</italic> in non-ASD symptoms of SMS (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). The locus for <italic>Lgl1</italic> lies within a refined consensus deletion site of ∼950 kb for SMS that has been reported in genetic studies of patients carrying the chromosomal deletion (<xref ref-type="bibr" rid="bib31">Vlangos et al., 2003</xref>). Fluorescence <italic>in situ</italic> hybridization probes targeting the sequence for the human homolog of <italic>Lgl1</italic> fail to hybridize with one of the copies of chromosome 17 in patients with SMS (<xref ref-type="bibr" rid="bib20">Koyama et al., 1996</xref>). The functional role of <italic>Lgl1</italic> in SMS has not been reported.</p>
<p id="p0050">We found that <italic>Lgl1</italic> conditional KO in excitatory neurons from early postnatal stages (P7) resulted in behavioral deficits in adulthood, such as hyperactivity, cognitive impairment, and social interaction defects. We found that <italic>Lgl1+/−</italic> animals also had higher synapse numbers and showed impaired social interaction and increased stereotyped repetitive behaviors. Patients with SMS show either seizures or abnormal electroencephalography (EEG) without overt seizure (<xref ref-type="bibr" rid="bib3">Chen et al., 1996</xref>, <xref ref-type="bibr" rid="bib13">Greenberg et al., 1996</xref>). We found that <italic>Lgl1+/−</italic> animals have lower seizure threshold. Because our electrophysiological and biochemical results suggest higher NMDA activity in <italic>Lgl1</italic> mutants, we tested whether NMDA blockers could rescue any of the behavioral deficits and found that low-dose ketamine, MK801, and memantine could rescue the social interaction deficit of <italic>Lgl+/−</italic> animals. Therefore, apical-basal cell polarity signaling components are also essential for normal synaptic function and the loss of their function may cause neuropsychiatric disorders; these NMDA blockers may help alleviate certain behavioral symptoms of SMS patients with <italic>Lgl1</italic> deletion.</p>
</sec>
<sec id="sec2">
<title>Results</title>
<sec id="sec2.1">
<title>Increased Glutamatergic Synapse Numbers and Reduced AMPA/NMDA Ratio in <italic>Lgl1</italic> Conditional Knockout <italic>In Vivo</italic></title>
<p id="p0055">Glutamatergic synapse formation starts shortly after birth. Lgl1 has roles in earlier stages of development, including neurogenesis. To avoid early developmental defects, we conditionally knocked out <italic>Lgl1</italic> in hippocampal pyramidal neurons from postnatal day 7 (P7) using an inducible <italic>Cre</italic> line, <italic>SLICK-H</italic> (<xref ref-type="supplementary-material" rid="mmc1">Figures S1</xref>A–S1C) (<xref ref-type="bibr" rid="bib15">Heimer-McGinn and Young, 2011</xref>). Tamoxifen was injected intraperitoneally on P7 and postnatal day 8 (P8) and animals were euthanized and perfused on postnatual day 14 (P14) for electron microscopy. We counted asymmetric and symmetric synapses in the stratum radiatum. Images were taken 150–200 μm from the CA1 cell body layer in brain slices. We observed a 28.7% increase in the density of asymmetric (excitatory) synapse that are formed on dendritic spines (<xref ref-type="fig" rid="fig1">Figure 1</xref>A). Axo-dendritic synapses show no change in density. No significant change was observed in symmetric (inhibitory) synapse density in these slices.<fig id="fig1"><label>Figure 1</label><caption><p><italic>Lgl1 Conditional Knockout</italic> in Pyramidal Neurons Led to Increased Numbers of Asymmetric Synapses</p><p>(A) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of P14 mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Scale bar, 500 nm. Quantification of synapse numbers corresponding to each region: N = 6 control, 6 <italic>Lgl1</italic> cKO animals.</p><p>(B) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of 8-week-old mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Quantification of synapse numbers corresponding to each region: N = 5 control, 5 <italic>Lgl1</italic> cKO animals.</p><p>(C) Representative traces of mEPSC recordings from acute slices from P13–P15 control and <italic>Lgl1</italic> cKO mice. Quantification of mEPSC frequency and amplitude: n = 22 control, 19 <italic>Lgl1</italic> cKO neurons.</p><p>(D) Representative traces of mIPSC recordings from acute slices from P14 control and <italic>Lgl1</italic> cKO mice. Quantification of mIPSC frequency and amplitude: n = 20 control, 19 <italic>Lgl1</italic> cKO neurons.</p><p>(E) Representative confocal images of oblique CA1 dendrites filled with Alexa Fluor 555 hydrazide. Scale bar, 10 μm.</p><p>(F and G) (F) Quantification of spine density and (G) distribution of spine morphology.</p><p>(H) Quantification of cumulative distributions of synapse ultrastructure measurements in P14 control and cKO animals: n = 194 control, 174 <italic>Lgl1</italic> cKO synapses. Quantification of cumulative distributions of synapse ultrastructure measurements in 8-week old control and cKO animals: n = 194 control, 208 <italic>Lgl1</italic> cKO synapses.</p><p>(I) Biochemical fractionation from wild-type P14 mice. P2, crude synaptosomal; SMF, synaptic membrane fraction; PSD, postsynaptic density.</p><p>(J) Representative traces of NMDAR currents and combined AMPAR/NMDAR currents from acute slices taken from P14 control and <italic>Lgl1</italic> cKO mice following Lgl1 deletion at P7. Scale bar, 100 pA (vertical); 100 ms (horizontal). Quantification of the calculated ratio of AMPAR current to NMDAR current: n = 13 control, 13 <italic>Lgl1</italic> cKO neurons.</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0060">To determine whether the increased synapses persist, we fixed slices from 8-week old adult mice that had tamoxifen injection at P7 and P8. In these animals, we observed an increase of 31.8% in asymmetric synapse density 150–200 μm from the CA1 cell body layer (<xref ref-type="fig" rid="fig1">Figure 1</xref>B). In contrast to juvenile animals, adult animals show a statistically significant 25.5% increase in density of symmetric synapses in the region 50 μm from the CA1 cell layer. The delay in the increase of symmetric synapses suggests that it is not directly caused by the loss of function of <italic>Lgl1</italic>, but possibly by a homeostatic response of the hippocampal circuitry. The number of asymmetric synapses in the region 50 μm from the CA1 cell layer also shows an increase (<xref ref-type="supplementary-material" rid="mmc1">Figures S1</xref>D and S1E).</p>
<p id="p0065">To assess the function of the increased synapses, we recorded miniature excitatory postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) from acute brain slices from P14 and P15 control and <italic>Lgl1 cKO</italic> animals. Quantification of frequency and amplitude of synaptic currents indicates that mEPSC frequency was increased by 38%, whereas amplitude was not changed significantly, indicating an increase in synapse number but similar AMPA-R composition (<xref ref-type="fig" rid="fig1">Figure 1</xref>C). No significant changes were observed in mIPSC currents (<xref ref-type="fig" rid="fig1">Figure 1</xref>D), consistent with our electron microscopy data. Consistent with this, cultured hippocampal neurons from mice carrying germline deletion of <italic>Lgl1</italic> also showed increased colocalization between PSD95 and vGlut1 puncta at 14 days <italic>in vitro</italic> (<xref ref-type="supplementary-material" rid="mmc1">Figures S1</xref>F and S1G). mEPSC kinetics did not show significant changes (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>H), whereas mIPSC kinetics only showed a significant decrease in decay time constant, but not in other measures (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>I).</p>
<p id="p0070">To determine whether dendritic spine density was affected, we filled neurons from fixed brain sections with Alexa 555 dye to visualize spines in yellow fluorescent protein (YFP)-positive CA1 pyramidal neurons (<xref ref-type="fig" rid="fig1">Figure 1</xref>E). We found that overall spine density was indeed increased by 38% in <italic>Lgl1</italic> cKO mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>F). We also characterized the morphology of spines at P14. Compared with control, <italic>Lgl1</italic> cKO mice showed more mushroom spines and a reduced proportion of stubby spines (<xref ref-type="fig" rid="fig1">Figure 1</xref>G). As mushroom spines represent stabilized synapses and thin spines are unstable, this suggests that <italic>Lgl1</italic> cKO led to functionally hyperconnected circuits. Consistent with this, we then quantified the ultrastructure from the electron micrograph and found that the length of postsynaptic density (PSD) was increased and the gap of synaptic cleft was reduced at P14 and at age 8 weeks (<xref ref-type="fig" rid="fig1">Figure 1</xref>H). As Lgl1 interacts with the MAGUK proteins, we determined the subcellular localization and found that Lgl1 was present in the postsynaptic density (<xref ref-type="fig" rid="fig1">Figure 1</xref>I). We also measured AMPA/NMDA ratio, and found that the ratio is decreased in the <italic>Lgl1 cKO</italic>, suggesting altered glutamate receptor trafficking or function (<xref ref-type="fig" rid="fig1">Figure 1</xref>J).</p>
</sec>
<sec id="sec2.2">
<title>Lgl1 Negatively Regulates Synapse Number by Inhibiting the Atypical PKCs</title>
<p id="p0075">As Lgl1 and aPKC antagonize each other in cell polarity signaling, we asked whether Lgl1 may regulate synapse formation by inhibiting the aPKCs. To validate whether Lgl1 also inhibits the aPKCs in neurons, we tested their interaction in neural progenitor cells from E11.5 mouse telencephalon. <italic>Lgl1</italic> cKO and control cells were generated by treatment of cultures with AD5-CMV-Cre and Ad5-CMV-GFP adenoviruses (Vector Development Laboratory, Baylor College of Medicine), respectively, and verified that Lgl1 protein was completely lost in the cKO (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A). We then tested whether aPKC activity, as evident by association with Par3, was increased in <italic>Lgl1</italic> cKO. Activated aPKC (phosphorylated at T555) and aPKC interaction with Par3 were found strongly increased in <italic>Lgl1</italic> cKO, confirming the increase of apical signaling and decrease of basal-lateral signaling.</p>
<p id="p0080">There are two isoforms of aPKCs in mouse. We used the same strategy of tamoxifen-induced deletion of <italic>aPKC</italic>s using <italic>SLICK-H</italic> to delete both isoforms of <italic>aPKCs, PKCι/λ</italic> and <italic>PKCζ,</italic> to eliminate the possibility of compensation. Following this deletion, we counted asymmetric and symmetric synapses from the schaffer collateral 150 μm from the CA1 cell layer of 2- and 8-week-old animals. At 2 weeks, we observed no significant difference in the number of asymmetric or symmetric synapses (<xref ref-type="fig" rid="fig2">Figure 2</xref>A). However, at 8 weeks, there was a significant decrease (−16.1%) in the number of asymmetric synapses (<xref ref-type="fig" rid="fig2">Figure 2</xref>B). In the proximal region 50 μm from the CA1 cell body layer, we also observed a significant decrease at 8 weeks, but not at 2 weeks (<xref ref-type="supplementary-material" rid="mmc1">Figures S2</xref>B and S2C). Therefore, aPKC is not essential for initial glutamatergic synapse formation but required for their stability and maintenance. We then analyzed the ultrastructure and found that the PSD width was reduced at 2 weeks and the synaptic cleft was increased at 2 weeks and that the magnitude of this change increased at 8 weeks (<xref ref-type="fig" rid="fig2">Figure 2</xref>C). This suggests that aPKC is likely important for the stability of synapses, the opposite of Lgl1 (<xref ref-type="fig" rid="fig1">Figure 1</xref>H).<fig id="fig2"><label>Figure 2</label><caption><p>Lgl1 Inhibits Synapse Formation by Inhibiting aPKC and Promotes the Expression of Vangl2</p><p>(A) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of P14 mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Scale bar, 500 nm. Quantification of synapse numbers corresponding to each region: N = 8 control, 5 <italic>aPKC dcKO</italic> animals.</p><p>(B) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of 8-week-old mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Quantification of synapse numbers corresponding to each region: N = 5 control, 8 <italic>aPKC dcKO</italic> animals.</p><p>(C) Quantification of cumulative distribution of synapse ultrastructure measurements in P14 control and cKO animals: n = 194 control, 129 <italic>aPKC dcKO</italic> synapses. Quantification of cumulative distribution of synapse ultrastructure measurements in 8-week-old control and cKO animals: n = 87 control, 168 <italic>aPKC dcKO</italic> synapses.</p><p>(D) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of P14 mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Scale bar, 500 nm. Quantification of synapse numbers corresponding to each region: N = 7 control, 6 <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals.</p><p>(E) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of 8-week-old mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Quantification of synapse numbers corresponding to each region: N = 8 control, 10 <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals.</p><p>(F) Levels of Vangl2 and JAM-C proteins in P2 fractions by Western blots.</p><p>(G) Quantification of Vangl2 and JAM-C protein levels in P2 fraction. N = 5 for Vangl2. N = 4 for JAM-C.</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption><graphic xlink:href="gr2"></graphic></fig></p>
<p id="p0085">We then asked whether simultaneous deletion of <italic>Lgl1</italic>, <italic>PKCι/λ,</italic> and <italic>PKCζ</italic> might lead to mitigation of the effects observed in the <italic>Lgl11</italic> conditional deletion experiments. In 2-week-old <italic>Lgl1</italic>:<italic>PKCι/λ</italic>:<italic>PKCζ</italic> tcKO animals, we observe no significant change in asymmetric synapse number, suggesting that the increase of synapse numbers in <italic>Lgl1 cKO</italic> may be partly due to the increase of aPKC activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>D). However, we observed a significant decrease (−25.9%) in the number of symmetric synapses. In 8-week-old <italic>Lgl1</italic>:<italic>PKCι/λ</italic>:<italic>PKCζ</italic> tcKO animals, we observed no significant change in asymmetric or symmetric synapse number (<xref ref-type="fig" rid="fig2">Figure 2</xref>E). No significant difference in asymmetric synapse density was observed in the proximal region at 2 and 8 weeks (<xref ref-type="supplementary-material" rid="mmc1">Figures S3</xref>A and S3B). Therefore, Lgl1 may negatively regulate glutamatergic synapse numbers by inhibiting aPKC, which is required for the stability and maintenance of glutamatergic synapses.</p>
<p id="p0090">Because PCP proteins regulate synapse formation and apical-basal polarity signaling regulates the localization PCP signaling components, we tested whether Lgl1 may regulate PCP components using synaptosome fractionation. The SLICK-H line (inducible Cre) expresses Cre in only 60% of pyramidal neurons at P7. Therefore, we cultured neurons from <italic>Lgl1</italic> KOs, heterozygotes, and wild-type and extracted synaptosome fraction. We found that Vangl2 protein levels are decreased in the P2 fractions of <italic>Lgl1+/−</italic> and <italic>Lgl1−/−</italic> compared with that of the <italic>wild-type</italic> (<xref ref-type="fig" rid="fig2">Figure 2</xref>F), whereas the levels of an adhesion molecule Jam-C were not affected (<xref ref-type="fig" rid="fig2">Figure 2</xref>G). This is consistent with the inhibitory function of Vangl2 in glutamatergic synapse formation.</p>
</sec>
<sec id="sec2.3">
<title>Lgl1 Controls Glutamatergic Synapse Number and Is Required for Synaptic Plasticity in Adulthood</title>
<p id="p0095">Because <italic>Lgl1</italic> is highly expressed in the adult central nervous system, including the hippocampus, we next characterized the role of Lgl1 in the adult brain. By early adulthood at age 6 weeks, synapse formation has slowed considerably in the rodent hippocampus compared with postnatal development (<xref ref-type="bibr" rid="bib32">Wang et al., 2007</xref>). We conditionally knocked out <italic>Lgl1</italic> by injecting tamoxifen at 6 weeks after birth in SLICK-H animals. We then used electron microscopy to assess the density of asymmetric and symmetric synapses in the schaffer collateral in 10-week-old animals. Asymmetric synapse density in the region 150–200 μm distal to the CA1 cell body layer was again increased by 28.6% on the dendritic spines (<xref ref-type="fig" rid="fig3">Figures 3</xref>A and 3B). A similar increase was observed in the proximal region 50 μm from the CA1 cell layer (<xref ref-type="fig" rid="fig3">Figures 3</xref>C and 3D). Symmetric synapses were again unaffected (<xref ref-type="fig" rid="fig3">Figures 3</xref>E and 3F). In addition, synapse ultrastructure was altered in the adult deletion of <italic>Lgl1</italic>, with longer and wider PSDs (<xref ref-type="fig" rid="fig3">Figures 3</xref>G and 3H) and smaller synaptic clefts (<xref ref-type="fig" rid="fig3">Figure 3</xref>I), possibly as a result of altered biochemical makeup of synapses. We performed patch clamping with P42 slices to assess the synaptic receptor expression from animals with <italic>Lgl1</italic> deleted beginning at P28. We observed a severe reduction in the AMPA/NMDA ratio in neurons from <italic>Lgl1</italic> cKO mice (<xref ref-type="fig" rid="fig3">Figures 3</xref>J and 3K), much greater than was observed at P14 following deletion of <italic>Lgl1</italic> at P7/P8. These results suggest that <italic>Lgl1</italic> is also required for control of synapse number and quality in adulthood.<fig id="fig3"><label>Figure 3</label><caption><p>Increased Synapse Numbers, Altered AMPA/NMDA Ratio, and Impaired Plasticity in Adult Conditional Knockout of <italic>Lgl1</italic></p><p>(A) Electron micrographs of the schaffer collateral (SC) 150–200 μm ventral to the CA1 pyramidal cell layer of slices from 10-week-old control and <italic>Lgl1</italic> cKO mice following deletion of Lgl1 beginning at 6 weeks of age. Red arrows denote asymmetric synapses. Scale bar, 500 nm. N = 6 control, 8 <italic>Lgl1</italic> cKO animals.</p><p>(B) Quantification of asymmetric synapse density of the region described in <xref ref-type="fig" rid="fig5">Figure 5</xref>A.</p><p>(C) Electron micrographs of the SC 50 μm ventral to the CA1 pyramidal cell layer in 10-week-old animals.</p><p>(D) Quantification of asymmetric synapses in the proximal region.</p><p>(E) Micrographs showing symmetric synapses (black arrows) in the proximal region of the SC.</p><p>(F) Quantification of symmetric synapses.</p><p>(G) Quantification of cumulative frequency for postsynaptic density (PSD) length.</p><p>(H) Quantification for PSD width.</p><p>(I) Quantification of synaptic cleft distance. n = 180 <italic>Lgl1</italic> control synapses, 242 <italic>Lgl1</italic> cKO synapses.</p><p>(J) Representative traces of NMDAR current and combined AMPAR/NMDAR current from acute slices taken from 6-week-old control and <italic>Lgl1</italic> cKO mice following Lgl1 deletion beginning at P28. Scale bar, 50 pA, 80 ms.</p><p>(K) Quantification of the calculated ratio of AMPAR to NMDAR current. N = 5 control, 7 <italic>Lgl1</italic> cKO neurons.</p><p>(L) Representative traces of EPSPs before and after TBS stimulation was delivered to acute slices from control and <italic>Lgl1</italic> cKO mice. Scale bar, 0.2 mV, 10 ms.</p><p>(M) Quantification of EPSP slope before and after theta burst stimulation (TBS). N = 5 <italic>Lgl1</italic> control, 4 <italic>Lgl1</italic> cKO.</p><p>(N) Quantification of paired-pulse ratio from control and <italic>Lgl1</italic> cKO animals deleted at 6 weeks. N = 6 <italic>Lgl1</italic> control, 6 <italic>Lgl1</italic> cKO.</p><p>*p &lt; 0.05; **p &lt; 0.01; ****p &lt; 0.0001.</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
<p id="p0100">We tested synaptic plasticity using hippocampal slices from 10-week old mice following conditional <italic>Lgl1</italic> deletion at age 6 weeks. Slices from <italic>Lgl1</italic> cKO animals showed impaired long-term potentiation induction in response to theta burst stimulation (TBS) (<xref ref-type="fig" rid="fig3">Figures 3</xref>L–3M). In addition, slices from <italic>Lgl1</italic> cKO mice showed impaired paired-pulse facilitation when stimuli were separated by 100 ms (<xref ref-type="fig" rid="fig3">Figure 3</xref>N), indicating altered synaptic release.</p>
</sec>
<sec id="sec2.4">
<title><italic>Lgl1</italic> cKO Mice Showed Behavioral Deficits</title>
<p id="p0105"><italic>Lgl1</italic> is frequently deleted in SMS. But the genes responsible for the behavioral symptoms of SMS have not been well understood. To test whether deletion of <italic>Lgl1</italic> in pyramidal neurons may contribute to the behavioral deficits, we performed a number of behavioral tests. We assessed locomotor activity and exploratory behavior using an open field test (<xref ref-type="fig" rid="fig4">Figure 4</xref>A; <xref ref-type="bibr" rid="bib12">Gould et al., 2009</xref>). <italic>Lgl1 cKO</italic> animals showed increased locomotor activity, traveling 20% further during the 10-min test than control mice (<xref ref-type="fig" rid="fig4">Figure 4</xref>B). No significant changes were observed in thigmotaxis, the preference for the outside of the field versus the center region (<xref ref-type="fig" rid="fig4">Figure 4</xref>C). Animals did not show a difference in the amount of time spent self-grooming during the open-field test (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>A), but showed a significant increase in rearing activity, an exploratory behavior (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>B).<fig id="fig4"><label>Figure 4</label><caption><p><italic>Lgl1</italic> Deletion at P7 Produced a Subset of SMS-like Behavioral Phenotypes</p><p>(A) Open-field analysis following P7 deletion of Lgl1 showing representative trajectories (left) and heatmaps (right) of control and <italic>Lgl1</italic> cKO animals.</p><p>(B) Quantification of distance traveled during the test. N = 30 control, 27 <italic>Lgl1</italic> cKO.</p><p>(C) Quantification of time spent in the outer region of the field (thigmotaxis) during the first and second 5-min periods.</p><p>(D and E) (D) Representative heatmap and quantification (E) of animal preference for objects during the sample phase of the novel object recognition (NOR) test. N = 23 control, 19 <italic>Lgl1</italic> cKO animals.</p><p>(F and G) (F) Representative heatmaps and quantification (G) of animal preference for objects during the test phase of the NOR test. White asterisk denotes location of the novel object.</p><p>(H) Representative heatmaps from the habituation period of the social interaction (SI) test.</p><p>(I and J) (I) Quantification of time spent in and (J) preference for regions of interest (ROIs) representing future location of novel mice and objects. N = 25 control, 24 <italic>Lgl1</italic> cKO animals.</p><p>(K) Representative heatmaps during the social interaction phase of the SI test. White asterisk denotes location of the novel mouse. Opposite chamber contains the object.</p><p>(L and M) (L) Quantification of time spent in and (M) preference for ROIs containing either the novel mouse or novel object. Positive value indicates preference for the novel mouse. N = 25 control, 22 <italic>Lgl1</italic> cKO animals.</p><p>(N) Representative heatmaps during the social novelty phase of the SI test. White asterisk denotes location of the novel mouse. Opposite chamber contains the previously explored mouse.</p><p>(O and P) (O) Quantification of time spent interacting with and (P) preference for mice during the social novelty phase. Positive value indicates preference for the novel mouse. N = 20 control, 14 <italic>Lgl1</italic> cKO animals. NS, nonsocial; S, social.</p><p>∗p &lt; 0.05; ∗∗p &lt; 0.01; ∗∗∗p &lt; 0.001.</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
<p id="p0110">To assess cognitive function following conditional <italic>Lgl1</italic> deletion, we tested the <italic>Lgl1 cKO</italic> crossed with SLICK-H in the novel object recognition (NOR) paradigm. The NOR test assesses whether an animal can distinguish a novel object from a previously explored familiar object. We calculated a preference index from each animal by subtracting the familiar object interaction time from the novel exploration time and normalizing to the total exploration time ((novel-familiar)/(novel + familiar)). During the sample phase, when both objects were novel, animals showed no preference and would randomly explore both objects (<xref ref-type="fig" rid="fig4">Figures 4</xref>D and 4E). When a novel object was introduced after a 2-min delay, control animals showed a strong preference for the novel object, whereas <italic>Lgl1</italic> cKO animals continued to explore randomly and maintain a preference index close to zero (<xref ref-type="fig" rid="fig4">Figures 4</xref>F and 4G).</p>
<p id="p0115">Brain hyperconnectivity has been associated with ASDs (<xref ref-type="bibr" rid="bib6">Dominguez et al., 2013</xref>, <xref ref-type="bibr" rid="bib18">Keown et al., 2013</xref>, <xref ref-type="bibr" rid="bib29">Supekar et al., 2013</xref>). Sociability in the three-chamber social interaction task has been used extensively to assess social behavior in mice (<xref ref-type="bibr" rid="bib36">Yang et al., 2011</xref>). We tested <italic>Lgl1 cKO</italic> mice crossed with SLICK-H to assess their sociability (<xref ref-type="fig" rid="fig4">Figures 4</xref>H–4P). Before introduction of the target mouse, animals showed no preference for either side, exploring the field randomly (<xref ref-type="fig" rid="fig4">Figures 4</xref>H–4J). When a mouse was introduced to one side of the field, whereas an empty enclosure was introduced to the opposite side, control animals showed a strong preference for interacting with the novel mouse. <italic>Lgl1 cKO</italic> animals showed no preference (<xref ref-type="fig" rid="fig4">Figures 4</xref>K–4M) and spent similar amount of time exploring the novel mouse and novel object. Interestingly, no statistically significant difference was observed in the final phase of the test where subject mice were given a choice between a familiar and novel target mouse (<xref ref-type="fig" rid="fig4">Figures 4</xref>N–4P). Similar to controls, <italic>Lgl1 cKO</italic> mice still appeared to show a preference for the novel mouse. <italic>Lgl1 cKO</italic> mice showed normal spatial memory by alternations and entries in the Y-maze (<xref ref-type="supplementary-material" rid="mmc1">Figures S4</xref>C and S4D) and normal visual performance (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>E). Hippocampal- and amygdala-dependent memory formation was spared in the conditioned fear task (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>F). Nestlet-shredding activity was unchanged in the conditional deletion of <italic>Lgl1</italic> (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>G).</p>
</sec>
<sec id="sec2.5">
<title><italic>Atypical PKC</italic> Deletion Partially Rescued Behavioral Deficits of <italic>Lgl1 cKO</italic></title>
<p id="p0120">Having observed synapse phenotypes in the conditional <italic>aPKC</italic> deletion, we then tested whether the changes would lead to behavioral deficits. In open-field test, <italic>PKCι/λ</italic> and <italic>PKCζ dcKO</italic> animals showed no significant changes in locomotor activity or thigmotaxis (<xref ref-type="fig" rid="fig5">Figures 5</xref>A–5C). We also assessed cognitive function and found that <italic>PKCι/λ</italic>:<italic>PKCζ dcKO</italic> were impaired in the novel object recognition test (<xref ref-type="fig" rid="fig5">Figures 5</xref>D and 5E). In the social interaction test, animals showed no preference before the introduction of the novel mouse (<xref ref-type="fig" rid="fig5">Figures 5</xref>F and 5G). Littermate control animals preferred social interaction, spending more time with the novel mouse versus the novel object, whereas <italic>PKCι/λ</italic>:<italic>PKCζ dcKO</italic> spent similar amounts of time interacting with the novel mouse and novel object, maintaining a preference index close to 0 (<xref ref-type="fig" rid="fig5">Figures 5</xref>H and 5I). Preference for social novelty was unaffected by aPKC deletion (<xref ref-type="fig" rid="fig5">Figures 5</xref>J and 5K).<fig id="fig5"><label>Figure 5</label><caption><p>Conditional Triple Knockout of Lgl1, PKCι/λ, and PKCζ Rescued Asymmetric Synapse Number and Cognitive Deficit</p><p>(A) Open-field analysis following P7 deletion of Lgl1 showing representative trajectories (left) and heatmaps (right) of control and <italic>aPKC dcKO</italic> animals.</p><p>(B) Quantification of distance traveled during the test. N = 32 control, 26 <italic>aPKC dcKO</italic> animals.</p><p>(C) Quantification of time spent in the outer region of the field (thigmotaxis) during the first and second 5-min periods.</p><p>(D) Representative heatmap and quantification of animal preference for objects during the sample phase of the novel object recognition (NOR) test. N = 26 control, 15 <italic>aPKC dcKO</italic> animals.</p><p>(E) Representative heatmaps and quantification of animal preference for objects during the test phase of the NOR test. White asterisk denotes location of the novel object.</p><p>(F and G) (F) Quantification of time spent in and (G) preference for regions of interest (ROIs) representing future location of novel mice and objects. N = 35 control, 26 <italic>aPKC dcKO</italic> animals.</p><p>(H and I) (H) Quantification of time spent in and (I) preference for ROIs containing either the novel mouse or novel object. Positive value indicates preference for the novel mouse. N = 35 control, 27 <italic>aPKC dcKO</italic> animals. *p &lt; 0.05; **p &lt; 0.01.</p><p>(J and K) (J) Quantification of time spent interacting with and (K) preference for target mice during the social novelty phase. Positive value indicates preference for the novel mouse. N = 35 control, 27 <italic>aPKC dcKO</italic> animals. *p &lt; 0.05.</p><p>(L) Open-field analysis following P7 deletion showing representative trajectories (left) and heatmaps (right) of control and <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals.</p><p>(M) Quantification of distance traveled during the test. N = 20 control, 14 <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals.</p><p>(N and O) (N) Representative heatmap and quantification (O) of animal preference for objects during the sample phase of the novel object recognition (NOR) test. N = 21 control, 15 <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals.</p><p>(P and Q) (P) Representative heatmaps and quantification (Q) of animal preference for objects during the recognition test phase of the NOR test. White asterisk denotes location of the novel object.</p><p>(R and S) (R) Quantification of time spent in and (S) preference for ROIs representing future location of novel mice and objects.</p><p>(T and U) (T) Quantification of time spent in and (U) preference for ROIs containing either the novel mouse or novel object. Positive value indicates preference for the novel mouse.</p><p>(V and W) (V) Quantification of time spent interacting with and (W) preference for target mice during the social novelty phase. Positive value indicates preference for the novel mouse. N = 25 control, 19 <italic>Lgl1;PKCι/λ;PKCζ tcKO</italic> animals. NS, nonsocial; S, social.</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p></caption><graphic xlink:href="gr5"></graphic></fig></p>
<p id="p0125">We then tested locomotor activity and observed no difference between littermate control and <italic>Lgl1</italic>:<italic>PKCι/λ</italic>:<italic>PKCζ</italic> tcKO animals (<xref ref-type="fig" rid="fig5">Figures 5</xref>L–5M). However, triple conditional deletion of <italic>Lgl1</italic>, <italic>PKCι/λ,</italic> and <italic>PKCζ</italic> did rescue cognitive deficit in the novel object recognition test, with <italic>Lgl1</italic>:<italic>PKCι/λ</italic>:<italic>PKCζ</italic> tcKO animals performing similarly to littermate controls and better than chance (one-sample t test, p = 0.0262) in the test (<xref ref-type="fig" rid="fig5">Figures 5</xref>N–5Q). Our observations showed that conditional deletion of <italic>Lgl1</italic>, <italic>PKCι/λ</italic>, and <italic>PKCζ</italic> corrects synapse density changes observed and preserves cognitive function. In the social interaction test (<xref ref-type="fig" rid="fig5">Figures 5</xref>R–5W), tcKO animals still showed impairment in the social interaction phase (<xref ref-type="fig" rid="fig5">Figures 5</xref>T–5U), but not the social novelty phase (<xref ref-type="fig" rid="fig5">Figures 5</xref>V–5W).</p>
</sec>
<sec id="sec2.6">
<title><italic>Lgl1</italic> Heterozygotes Had Increased Synapse Numbers and Displayed Behavioral Deficits Suggesting a Role in Smith-Magenis Syndrome</title>
<p id="p0130">As SMS arises from heterozygous deletion of the critical region, we assessed the effects of germline heterozygous deletion of <italic>Lgl1</italic> in our mouse (<xref ref-type="bibr" rid="bib19">Klezovitch et al., 2004</xref>). We imaged hippocampal sections from 8-week-old control and <italic>Lgl1</italic> heterozygous animals from the germline <italic>Lgl1</italic> KO line using electron microscopy. In these animals, the region 150–200 μm from the CA1 cell body layer showed an increase in asymmetric synapse density, with a somewhat smaller but significant increase (22.6%; <xref ref-type="fig" rid="fig6">Figure 6</xref>A and proximal region: S5A) compared with what was observed when both copies were deleted in the conditional KO. Symmetric synapses were not affected. Analysis of synapse ultrastructure revealed longer and wider PSDs and smaller synaptic clefts (<xref ref-type="fig" rid="fig6">Figure 6</xref>B).<fig id="fig6"><label>Figure 6</label><caption><p><italic>Lgl1</italic>+/− Mice Showed Increased Synaptic Numbers and SMS-like Behavioral Phenotypes</p><p>(A) Electron micrographs taken 150–200 μm (top) or 50 μm (bottom) ventral to the CA1 pyramidal neuron layer in the schaffer collateral region of 8-week-old mice. Red arrows denote asymmetric synapses. Black arrows denote symmetric synapses. Scale bar, 500 nm. Quantification of synapse numbers corresponding to each region: N = 10 <italic>Lgl1</italic>+/−, 7 <italic>Lgl1</italic>+/− animals.</p><p>(B) Quantification of cumulative distribution of synapse ultrastructure measurements in 8-week old <italic>Lgl1</italic>+/+ and <italic>Lgl1</italic>+/− animals: n = 265 <italic>Lgl1</italic>+/+ synapses, 140 <italic>Lgl1</italic>+/− synapses.</p><p>(C) Representative heatmaps from the 1-h extended-duration open-field test for <italic>Lgl1</italic>+/+ and <italic>Lgl1</italic>+/− animals and quantification for distance traveled in the extended open-field test. N = 30 <italic>Lgl1</italic>+/+, 33 <italic>Lgl1</italic>+/−.</p><p>(D) Quantification of nestlet-shredding activity. N = 19 <italic>Lgl1</italic>+/+, 30 <italic>Lgl1</italic>+/− animals.</p><p>(E and F) (E) Representative heatmaps from the recognition test phase of the novel object recognition (NOR) test 24 h after the sample phase of the object. Quantification of object preference during the test phase 24 h after the sample phase. N = 25 <italic>Lgl1</italic>+/+, 32 <italic>Lgl1</italic>+/−. (F) Representative heatmaps during the social interaction phase of the social interaction (SI) test. White asterisk denotes location of the novel mouse. Quantification of interaction preference in the SI test. N = 25 <italic>Lgl1</italic>+/+, 33 <italic>Lgl1</italic>+/− animals.</p><p>∗p &lt; 0.05; ∗∗p &lt; 0.01; ∗∗∗p &lt; 0.001; ∗∗∗∗p &lt; 0.0001.</p></caption><graphic xlink:href="gr6"></graphic></fig></p>
<p id="p0135">In the open-field test, <italic>Lgl1</italic>+/− animals did not show a significant difference from control animals after 10 min (<xref ref-type="supplementary-material" rid="mmc1">Figures S5</xref>B and S5C). During an extended observation period of 60 min in the open field (<xref ref-type="fig" rid="fig6">Figure 6</xref>C), <italic>Lgl1</italic><sup><italic>+/−</italic></sup> animals showed increased locomotor activity by 12.0% overall.</p>
<p id="p0140">We also tested stereotyped repetitive behavior and found that <italic>Lgl1</italic>+/− animals showed increased nestlet shredding when given cotton nesting material in a novel cage (<xref ref-type="fig" rid="fig6">Figure 6</xref>D), shredding 59.4% more material during the test. As this behavior was not observed in <italic>Lgl1</italic> cKO, this is likely a result of <italic>Lgl1</italic> deletion in heterozygotes in the subcortical areas that are not affected by the <italic>Thy-1</italic>-dependent deletion in the <italic>Lgl1</italic> cKO animals crossed with SLICK-H.</p>
<p id="p0145">Preference for novel object recognition was spared in <italic>Lgl</italic>+/− animals (<xref ref-type="supplementary-material" rid="mmc1">Figures S5</xref>E–S5H) following a 2-min delay, suggesting that this cognitive task might be partially spared by either reduced impact on synapse density or synaptic function due to the remaining copy of <italic>Lgl1</italic>. Therefore, we performed an additional novel object recognition test, this time with a 24-h delay between the initial sample period and the recognition test. After 24 h, control animals successfully discriminated novel and familiar objects, whereas <italic>Lgl1</italic>+/− animals did not (<xref ref-type="fig" rid="fig6">Figure 6</xref>E). Patients with SMS demonstrate mild to moderate cognitive impairment or developmental delay, and it is likely that the partially preserved recognition of novel objects reflects a mild cognitive impairment in the mouse model.</p>
<p id="p0150">Similar to <italic>Lgl1</italic> cKO animals, <italic>Lgl1</italic>+/− animals demonstrated deficient social interaction, but spared preference for social novelty (<xref ref-type="fig" rid="fig6">Figures 6</xref>F, <xref ref-type="supplementary-material" rid="mmc1">S5</xref>I, and S5J), indicating that loss of one copy of <italic>Lgl1—</italic>as occurs in SMS<italic>—</italic>may be sufficient to give rise to ASD-like behaviors. <italic>Lgl1</italic>+/− animals did not show a difference from control littermates in age-dependent weight gain (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>K).</p>
</sec>
<sec id="sec2.7">
<title>Social Interaction Deficit in <italic>Lgl1+/−</italic> May Be Caused by Excessive NMDA Current</title>
<p id="p0155">Because SMS often presents with either seizures or abnormal EEG without overt seizure (<xref ref-type="bibr" rid="bib3">Chen et al., 1996</xref>, <xref ref-type="bibr" rid="bib13">Greenberg et al., 1996</xref>), we tested whether abnormally high synapse density and NMDA current would lower the seizure threshold in response to the GABA<sub>A</sub>-blocking drug pentylenetetrazol (PTZ). Following injection of 50 mg/kg PTZ, the occurrence and latency of activities indicating the onset of a seizure were recorded. All animals tested showed at least one instance of jumping or full-body jerking (<xref ref-type="fig" rid="fig7">Figure 7</xref>A), whereas <italic>Lgl1+/−</italic> animals showed a shorter latency to the behavior following PTZ administration (<xref ref-type="fig" rid="fig7">Figure 7</xref>B). <italic>Lgl1+/−</italic> animals also showed significantly higher occurrence and shorter latency to Straub Tail, indicating persistent muscle contraction, and also showed a similar effect for the occurrence of clonic-tonic seizures.<fig id="fig7"><label>Figure 7</label><caption><p>Decreased Seizure Threshold in <italic>Lgl1</italic>+/− Mice and Rescue of Social Interaction by NMDAR Blockade</p><p>(A) Quantification of the occurrence of jerking/jumping, Straub tail, and clonic-tonic seizures in <italic>Lgl1</italic>+/+ and <italic>Lgl1</italic>+/− animals following 50 mg/kg PTZ administration. Fisher's exact test.</p><p>(B) Quantification of the latency to the first observation of behaviors following 50 mg/kg PTZ administration. N = 17 <italic>Lgl1</italic>+/+, 15 <italic>Lgl1</italic>+/− animals. Mann-Whitney U statistic test.</p><p>(C) Representative heatmaps during the social interaction phase of the social interaction test following intraperitoneal injection with 50 μL saline, 30 mg/kg ketamine, 0.3 mg/kg MK-801, or 20 mg/kg memantine. White asterisk denotes location of the novel mouse.</p><p>(D and E) (D) Quantification of time spent in social (S) or nonsocial (NS) regions of interest and (E) interaction preference of treated animals. N = (saline) 17 <italic>Lgl1</italic>+/+, 19 <italic>Lgl1</italic>+/− animals; (ketamine) 14 <italic>Lgl1</italic>+/+, 17 <italic>Lgl1</italic>+/− animals; (MK-801) 13 <italic>Lgl1</italic>+/+, 14 <italic>Lgl1</italic>+/− animals; (memantine) 19 <italic>Lgl1</italic>+/+, 17 <italic>Lgl1</italic>+/− animals.</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption><graphic xlink:href="gr7"></graphic></fig></p>
<p id="p0160">The lower AMPA/NMDA ratio and unaffected AMPA current suggests that <italic>Lgl1</italic> mutants may have excessive NMDA current. We asked whether abnormal NMDAR-dependent signaling could underlie some of the behavioral deficit, especially social interaction, that we observed. We used pharmacological blockers of NMDARs and tested animals in the three-chamber social interaction test. Subanesthetic dose of ketamine has been shown to provide rapid blockage of NMDAR-dependent signaling. We tested social interaction with injection of 50 μL sterile saline and observed that control animals preferred social interaction, whereas <italic>Lgl1</italic>+/− mice did not show a preference (<xref ref-type="fig" rid="fig7">Figures 7</xref>C–7E). Following injection of 30 mg/kg ketamine, <italic>Lgl1</italic>+/− mice showed a clear preference for social interaction similar to what was observed from control animals (<xref ref-type="fig" rid="fig7">Figures 7</xref>C–7E). Preferences in habituation and social novelty phases are unaffected by saline or drug injection (<xref ref-type="supplementary-material" rid="mmc1">Figures S6</xref>A–S6D). Ketamine injection did not change nestlet-shredding activity (<xref ref-type="supplementary-material" rid="mmc1">Figure S6</xref>E). In addition, we also tested MK-801 (dizocilpine) at 0.3 mg/kg and memantine at 20 mg/kg and observed that <italic>Lgl1</italic>+/− strongly preferred social interaction, as did control mice (<xref ref-type="fig" rid="fig7">Figures 7</xref>C–7E). These results suggest that excessive NMDA current due to <italic>Lgl1</italic> deletion may contribute to some of the behavioral deficits and that inhibiting NMDARs may help alleviate some of the neuropsychiatric symptoms in SMS patients with <italic>Lgl1</italic> deletion.</p>
</sec>
</sec>
<sec id="sec3">
<title>Discussion</title>
<p id="p0165">Although many of the proteins in glutamatergic synapses have been identified and their roles in synapse formation and function have been studied, the signaling logic that orchestrates the assembly of hundreds of proteins into a highly organized and dynamic structure remains poorly known. We show here that a conserved apical-basal polarity signaling component, Lgl1, is localized in the PSD and regulates synapse numbers and compositions of key synaptic proteins and glutamate receptors, probably by inhibiting aPKC activity and via interactions with its conserved binding partners, particularly the MAGUKs. Atypical PKC has been studied for its role in memory formation and consolidation. Here we report that conditional deletion of both isoforms of aPKCs at P7 and P8 led to a reduction in synapse number in adulthood and cognitive and social deficits. The observation that deletion of Lgl1 or aPKC both lead to behavioral changes indicates that synapse number must be optimally controlled for behavioral functions and changes in either direction lead to impairment. Triple conditional knockout of Lgl1 and aPKC isoforms rescued the number of the asymmetric synapses and cognitive function, supporting their antagonistic functions in synapse formation. Lgl1 forms a basal complex with Discs Large, which is the homolog of MAGUKs, essential scaffold proteins in the postsynaptic density, which regulate trafficking and clustering of glutamate receptors. Therefore, loss of Lgl1 may lead to changes of MAGUKs and glutamate receptor compositions, such as the reduction of AMPA/NMDA ratio. It should be noted that we also observed a decrease of paired-pulse ratio in <italic>Lgl1 cKO</italic>, suggesting that there may also be presynaptic defects (<xref ref-type="fig" rid="fig3">Figure 3</xref>N). The Cre line we used here, <italic>SLICK-H</italic>, expresses CreERT2 in both CA3 and CA1 pyramidal neurons. Although Lgl1 was found to be present in the postsynaptic density (<xref ref-type="fig" rid="fig1">Figure 1</xref>I), Lgl1 may also have a function on the presynaptic side. This reduction of paired-pulse ratio may contribute to the altered synaptic function.</p>
<p id="p0170"><italic>Lgl1</italic> is frequently deleted in SMS; therefore, we performed a number of behavioral tests. cKO of <italic>Lg11</italic> from P7 and P8 led to behavioral deficits, including hyperactivity, cognitive impairment, and social interaction, consistent with the autism-like symptoms in SMS. As SMS involves the microdeletion of one of the chromosomes, we analyzed the <italic>Lgl1+/−</italic> mice and found that <italic>Lgl1+/−</italic> mice had increased synapse numbers, impaired social interaction, and increased stereotyped repetitive behavior, suggesting that <italic>Lgl1</italic> is a candidate gene that contributes to the autism-like symptoms of SMS with <italic>Lgl1</italic> deletion. Repetitive behaviors involve the striatum, where <italic>CreER</italic><sup><italic>T2</italic></sup> is not expressed in the SLICK-H line. This may explain why repetitive behavior defects were only observed in <italic>Lgl1+/−</italic>. There was a slowed habituation to the open field in <italic>Lgl1</italic>+/− and defects in novel object recognition. In summary, loss of both copies of <italic>Lgl1</italic> locally or only one copy of <italic>Lgl1</italic> globally could cause behavioral deficits related to a subset of autism-like symptoms of SMS. Interestingly, <italic>Lgl1</italic> cKO and <italic>Lgl1+/−</italic> animals did not show an increase in grooming behavior during open-field observation or signs of excessive self-grooming while in their home cage that characterizes other ASD-like mouse models (<xref ref-type="bibr" rid="bib25">Peça et al., 2011</xref>). Lgl1 appears to be important to maintaining proper synapse numbers and normal function of synapses even in adulthood as deleting <italic>Lgl1</italic> at 6 weeks still lead to increase of synapse numbers and changes of synapse structure and function. <italic>Lgl1</italic> may be a key molecule required for synaptic plasticity in adulthood as cKO led to impairment of long-term potentiation. Therefore the loss of <italic>Lgl1</italic> in SMS may underlie the neurobiological basis of behavioral symptoms. We propose that <italic>Lgl1</italic> is a candidate gene contributing to SMS. Our studies also give rise to a mouse model (<italic>Lgl1+/−</italic> mice) for SMS for understanding disease mechanisms and development of treatment. Indeed, we found that blockade of NMDARs rescues social deficits, suggesting that NMDARs may be promising therapeutic targets for SMS with <italic>Lgl1</italic> deletion.</p>
<sec id="sec3.1">
<title>Limitations of the Study</title>
<p id="p0175">In <xref ref-type="fig" rid="fig3">Figure 3</xref>K, the variability of the data is greater for the control compared to the <italic>Lgl1</italic> cKO. This is a weakness of our data. However, upon closer inspection of the results, all but one of the data points in the control are higher than all data points from the conditional knockout. Therefore, while the data quality is not ideal, we believe that the conclusion would hold even with a larger sample size.</p>
</sec>
</sec>
<sec id="sec4">
<title>Methods</title>
<p id="p0180">All methods can be found in the accompanying <xref ref-type="supplementary-material" rid="mmc1">Transparent Methods supplemental file</xref>.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betschinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mechtler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl</article-title>
<source/>Nature
          <volume>422</volume>
<year>2003</year>
<fpage>326</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">12629552</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Manian</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Koeuth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chinault</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome</article-title>
<source/>Nat. Genet.
          <volume>17</volume>
<year>1997</year>
<fpage>154</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">9326934</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>K.-S.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>The smith-magenis syndrome [del(17)p11.2]: clinical review and molecular advances</article-title>
<source/>Ment. Retard. Dev. Disabil. Res. Rev.
          <volume>2</volume>
<year>1996</year>
<fpage>122</fpage>
<lpage>129</lpage>
</element-citation>
</ref>
<ref id="bib4">
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuykin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ossipova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>S.Y.</given-names>
</name>
</person-group>
<article-title>Par3 interacts with Prickle3 to generate apical PCP complexes in the vertebrate neural plate</article-title>
<source/>Elife
          <volume>7</volume>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib5">
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collingridge</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kehl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McLennan</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus</article-title>
<source/>J. Physiol.
          <volume>334</volume>
<year>1983</year>
<fpage>33</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">6306230</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stieben</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Velazquez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shanker</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The imaginary part of coherency in autism: differences in cortical functional connectivity in preschool children</article-title>
<source/>PLoS One
          <volume>8</volume>
<year>2013</year>
<fpage>1</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="bib7">
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dykens</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Finucane</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gayley</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Brief report: cognitive and behavioral profiles in persons with smith-magenis syndrome</article-title>
<source/>J. Autism. Dev. Disord.
          <volume>27</volume>
<year>1997</year>
<fpage>203</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="pmid">9105971</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dykens</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.C.M.</given-names>
</name>
</person-group>
<article-title>Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome</article-title>
<source/>J. Intellect. Disabil. Res.
          <volume>42</volume>
<year>1998</year>
<fpage>481</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">10030444</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edelman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Finucane</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Gender, genotype, and phenotype differences in Smith–Magenis syndrome: a meta-analysis of 105 cases</article-title>
<source/>Clin. Genet.
          <volume>71</volume>
<year>2007</year>
<fpage>540</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="pmid">17539903</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgiou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marinari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Burden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baum</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability</article-title>
<source/>Curr. Biol.
          <volume>18</volume>
<year>2008</year>
<fpage>1631</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="pmid">18976918</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vlangos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Szomju</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Edelman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Trevors</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nezarati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bunyan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Genotype-phenotype correlation in Smith-Magenis syndrome: Evidence that multiple genes in 17p11.2 contribute to the clinical spectrum</article-title>
<source/>Genet. Med.
          <volume>8</volume>
<year>2006</year>
<fpage>417</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">16845274</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<element-citation id="sref12" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Gould</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kovacsics</surname>
<given-names>C.</given-names>
</name>
</person-group>
<chapter-title>The open field test</chapter-title>
<series>Mood and Anxiety Related Phenotypes in Mice</series>
<volume>42</volume>
<year>2009</year>
<publisher-name>Humana Press</publisher-name>
<fpage>1</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="bib13">
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Parke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Killian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dutton</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Multi-disciplinary clinical study of smith-magenis syndrome (deletion 17p11.2)</article-title>
<source/>Am. J. Med. Genet.
          <volume>62</volume>
<year>1996</year>
<fpage>247</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="pmid">8882782</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gropman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>New developments in Smith-Magenis syndrome (del 17p11.2)</article-title>
<source/>Curr. Opin. Neurol.
          <volume>20</volume>
<year>2007</year>
<fpage>125</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="pmid">17351481</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heimer-McGinn</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice</article-title>
<source/>Genesis
          <volume>49</volume>
<year>2011</year>
<fpage>942</fpage>
<lpage>949</lpage>
<pub-id pub-id-type="pmid">21671347</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Gozani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Molecular and neural functions of rai1, the causal gene for smith-magenis syndrome</article-title>
<source/>Neuron
          <volume>92</volume>
<year>2016</year>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">27710782</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wharton</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Apical-basal polarity, Wnt signaling and vertebrate organogenesis</article-title>
<source/>Semin. Cell Dev. Biol.
          <volume>17</volume>
<year>2006</year>
<fpage>214</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="pmid">16839789</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keown</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mulvey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Local functional overconnectivity in posterior brain regions is associated with symptom severity in autism spectrum disorders</article-title>
<source/>Cell Rep.
          <volume>5</volume>
<year>2013</year>
<fpage>567</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="pmid">24210815</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klezovitch</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Tapscott</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Vasioukhin</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice</article-title>
<source/>Genes Dev.
          <volume>18</volume>
<year>2004</year>
<fpage>559</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="pmid">15037549</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inazawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tomotsune</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2</article-title>
<source/>Cytogenet. Cell Res.
          <volume>72</volume>
<year>1996</year>
<fpage>78</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="bib21">
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laje</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Morse</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Autism spectrum features in Smith-Magenis syndrome</article-title>
<source/>Am. J. Med. Genet. C Semin. Med. Genet.
          <volume>154</volume>
<year>2010</year>
<fpage>456</fpage>
<lpage>462</lpage>
</element-citation>
</ref>
<ref id="bib22">
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macara</surname>
<given-names>I.G.</given-names>
</name>
</person-group>
<article-title>Parsing the polarity code</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <volume>5</volume>
<year>2004</year>
<fpage>220</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">14991002</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wolters</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Adaptive and maladaptive behavior in children with smith-magenis syndrome</article-title>
<source/>J. Autism. Dev. Disord.
          <volume>36</volume>
<year>2006</year>
<fpage>541</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="pmid">16570214</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monaghan</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Bridges</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Cotman</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>29</volume>
<year>1989</year>
<fpage>365</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">2543272</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peça</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Venkatraman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lascola</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Shank3 mutant mice display autistic like behaviours and striatal dysfunction</article-title>
<source/>Nature
          <volume>472</volume>
<year>2011</year>
<fpage>437</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">21423165</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Variability in clinical phenotype despite commonchromosomal deletion in Smith-Magenis syndrome[del(17)(p11.2p11.2)]</article-title>
<source/>Genet. Med.
          <volume>5</volume>
<year>2003</year>
<fpage>430</fpage>
<lpage>434</lpage>
<pub-id pub-id-type="pmid">14614393</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Dykens</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2)</article-title>
<source/>Am. J. Med. Genet.
          <volume>81</volume>
<year>1998</year>
<fpage>179</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">9613859</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.C.M.</given-names>
</name>
<name>
<surname>McGavran</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waldstein</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zonona</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lahr</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Magenis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Interstitial deletion of (17)(p11.2p11.2) in nine patients</article-title>
<source/>Am. J. Med. Genet. A
          <volume>24</volume>
<year>1986</year>
<fpage>393</fpage>
<lpage>414</lpage>
</element-citation>
</ref>
<ref id="bib29">
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Supekar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Khouzam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gaillard</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kenworthy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yerys</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vaidya</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Brain hyperconnectivity in children with autism and its links to social deficits</article-title>
<source/>Cell Rep.
          <volume>5</volume>
<year>2013</year>
<fpage>738</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">24210821</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Onishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>J.R.</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<article-title>Evidence for opposing roles of Celsr3 and Vangl2 in glutamatergic synapse formation</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>114</volume>
<year>2017</year>
<fpage>E610</fpage>
<lpage>E618</lpage>
<pub-id pub-id-type="pmid">28057866</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vlangos</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>D.K.C.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Refinement of the Smith–Magenis syndrome critical region to 950 kb and assessment of 17p11.2 deletions. Are all deletions created equally?</article-title>
<source/>Mol. Genet. Metab.
          <volume>79</volume>
<year>2003</year>
<fpage>134</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">12809645</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats</article-title>
<source/>Neuroscience
          <volume>149</volume>
<year>2007</year>
<fpage>739</fpage>
<lpage>746</lpage>
<pub-id pub-id-type="pmid">17935895</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watkins</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Excitatory amino acid transmitters</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>21</volume>
<year>1981</year>
<fpage>165</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">6112965</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Horikoshi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity</article-title>
<source/>J. Cell Sci.
          <volume>119</volume>
<year>2006</year>
<fpage>2107</fpage>
<lpage>2118</lpage>
<pub-id pub-id-type="pmid">16638806</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Horikoshi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ishiyama</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwamatsu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity</article-title>
<source/>Curr. Biol.
          <volume>13</volume>
<year>2003</year>
<fpage>734</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="pmid">12725730</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Automated three-chambered social approach task for mice</article-title>
<source/>Curr. Protoc. Neurosci.
          <volume>8</volume>
<year>2011</year>
<comment>Unit 8.26</comment>
</element-citation>
</ref>
<ref id="bib37">
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarnescu</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Betschinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nakamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dockendorff</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jongens</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Sisson</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Fragile X protein functions with lgl and the par complex in flies and mice</article-title>
<source/>Dev. Cell
          <volume>8</volume>
<year>2005</year>
<fpage>43</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">15621528</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mechanistic basis of MAGUK-organized complexes in synaptic development and signaling</article-title>
<source/>Nat. Rev. Neurosci.
          <volume>17</volume>
<year>2016</year>
<fpage>209</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">26988743</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="appsec2" sec-type="supplementary-material">
<title>Supplemental Information</title>
<p id="p0205">
<supplementary-material content-type="local-data" id="mmc1">
<caption>
<title>Document S1. Transparent Methods and Figures S1–S6</title>
</caption>
<media xlink:href="mmc1.pdf"></media>
</supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>This work was supported by <funding-source id="gs1">NIMH</funding-source> RO1 MH116667, <funding-source id="gs2">NIMH</funding-source> R21 MH099082, and a March of Dimes grant to Y.Z., <funding-source id="gs3">NIH</funding-source> Training grant Fellowships to S.T. (T32 NS007220-27) and J.S. (T32 GM007240-36), and 2014 NARSAD Young Investigator Award to S.T. We thank the Electron Microscopy Core Facility at UCSD School of Medicine for sample preparation and technical assistance and the Mouse Behavioral Assessment Core at the Scripps Research Institute for behavioral tests and helpful suggestions.</p>
<sec id="sec5">
<title>Author Contributions</title>
<p id="p0190">Y.Z. and J.S. designed the experiments. J.S., S.T., Y.M., H.Q., H.H., S.-Y.L., and T.Y. performed the experiments and analyzed the results. O.K. and V.V. provided the Lgl1 KO and cKO mice. H.C., Y.M., and S.G. provided aPKC cKOs. Y.Z. and J.S. wrote the manuscript.</p>
</sec>
<sec id="sec6" sec-type="COI-statement">
<title>Declaration of Interests</title>
<p id="p0195">Y.Z. is the founder of VersaPeutics and VersaChem. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies.</p>
</sec>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="appsec1">
<p id="p0200">Supplemental Information can be found online at <ext-link ext-link-type="uri" id="intref0010" xlink:href="https://doi.org/10.1016/j.isci.2019.09.005">https://doi.org/10.1016/j.isci.2019.09.005</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>